Feasibility of Collateral Information Review and Its Impact on Clinical Decision-Making
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This project will investigate how review of collateral information sources (CIS) may impact clinical decision-making across the lifespan.
Condition or disease
Depressive DisorderAnxiety Disorders
This study aims to explore how reviewing collateral information sources (CIS) may affect clinical decision-making for clinicians treating participants with varied mood disorders. Investigators will assess the types of collateral information used in the clinical setting and treatment decisions made after a clinical session. We will gather this information from interested clinicians who will provide this information after each patient visit over the course of one week.
Rate of Use of the McLean Treatment Tracking Survey [ Time Frame: Over the course of 1 week ]
Clinicians will find the McLean Treatment Tracking Survey easy to use in their clinical care.
Rate of Completion of the McLean Treatment Tracking Survey [ Time Frame: Over the course of 1 week ]
The McLean Treatment Tracking Survey (MTTS) will better reflect collateral information reviewed in a clinical visit, as well as treatment decisions made. Investigators will compare responses from the MTTS with clinical notes recorded in patients' charts.
Secondary Outcome Measures :
Clinical Outcome - Increased treatment decisions made [ Time Frame: Over the course of 1 week ]
Investigators will explore whether reviewing more collateral information sources leads to more clinical actions taken for treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 85 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
- Clinicians from McLean Hospital Outpatient Programs (geriatric, child and adult) and the McLean Behavioral Health Partial Program, which predominantly treat patients with mood disorders.
Credentialed to provide psychopharmacology or psychotherapy at McLean and Licensed by the State of Massachusetts
Practice pharmacotherapy and either adjunctive or stand-alone evidence-based psychotherapy (e.g., CBT, DBT, supportive psychotherapy, etc.)
Fluent in English
Clinicians who do not meet the inclusion criteria detailed above